TOP1 and hyperphosphatemia: It is clear from the plot that antipropulsives, coxibs, drugs for treatment of hyperkalemia and hyperphosphatemia, oral bowel cleansers, other antineoplastic agents, and TOP1 inhibitors were associated with death in more than 10% of the cases in each category.